H1N1 Flu (Swine Flu)
Also known as: Swine flu
Methodology & AI Transparency ⓘ
H1N1 Flu (Swine Flu) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Swine flu is an infection caused by a virus.
- 2 Real-world patient consensus: Diagnostic registry A49.1: H1N1 Flu (Swine Flu) is managed within Infections & Antivirals (aka Swine flu).
- 3 Typical cash cost range: Clinicians assessing H1N1 Flu (Swine Flu) focus on or latent viral in H1N1 Flu (Swine Flu) (A49.1: reactivation within sensory) and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in H1N1 Flu (Swine Flu): maintaining C-Reactive Protein / in H1N1 Flu (Swine Flu) (A49.1: Procalcitonin) within Resolution to baseline (A49.1).
Ask our AI Specialists anything about H1N1 Flu (Swine Flu)
What Is H1N1 Flu (Swine Flu)?
Swine flu is an infection caused by a virus. It's named for a virus that pigs can get. People do not normally get swine flu, but human infections can and do happen. In 2009 a strain of swine flu called H1N1 infected many people around the world. The virus is contagious and can spread from human to human. Symptoms of swine flu in people are similar to the symptoms of regular human flu and include fever, cough, sore throat, body aches, headache, chills and fatigue. There are antiviral medicines you can take to prevent or treat swine flu. There is a vaccine available to protect against swine flu.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in H1N1 Flu (Swine Flu) (A49.1) features or latent viral in H1N1 Flu (Swine Flu) (A49.1: reactivation within sensory). Cross-referenced with NIH MeSH (Influenza A Virus, H1N1 Subtype, Influenza, Human), therapeutic stabilization in infections & antivirals is verified against Targeted PCR / in H1N1 Flu (Swine Flu) (A49.1: Culture & Sensitivity).
Common Symptoms & Clinical Signs
- • Covering your nose and mouth with a tissue when you cough or sneeze. Throw the tissue in the trash after you use it
- • Washing your hands often with soap and water, especially after you cough or sneeze. You can also use alcohol-based hand cleaners
- • Presentation of H1N1 Flu (Swine Flu) (A49.1): sore throat, productive in H1N1 Flu (Swine Flu) (A49.1: cough, sinus/ear pain,)
- • Secondary H1N1 Flu (Swine Flu) clinical sign: painful vesicular rash in H1N1 Flu (Swine Flu) (A49.1: in a dermatomal)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
H1N1 Flu (Swine Flu) Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | A49.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Bacterial, Viral & Fungal Infections | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: C-Reactive Protein / in H1N1 Flu (Swine Flu) (A49.1: Procalcitonin) | Resolution to baseline (A49.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Targeted PCR / in H1N1 Flu (Swine Flu) (A49.1: Culture & Sensitivity) | Pathogen clearance / negative test (A49.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Complete Blood Count in H1N1 Flu (Swine Flu) (A49.1: (WBC & Differential)) | WBC 4.0 – 10.0 x10^3/uL (A49.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for H1N1 Flu (Swine Flu)
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Mupirocin Ointment Dermacinrx Clorhexacin • RxCUI RXN-81033032-2271 | RNA Synthetase Inhibitor Antibacterial | 78% | $0.1366 | $ 14.03 /mo |
| Jublia (Efinaconazole) Jublia • RxCUI RXN-B01875400 | Azole Antifungal | 88% | $0.2900 | $ 29.38 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (H1N1 Flu (Swine Flu))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 In a post hoc analysis of the phase 2b study, compared with placebo, ensitrelvir demonstrated a reduced time to resolution of 5 symptoms in patients with mild-to-moderate COVID-19. Medicine • 2023-02-22 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 36827007 ↗ |
| Can This Approach Help? Inside the Latest Research on [Evaluation of the real-world benefits and safety of a complex antiviral drug Raphamin promotes significant decrease, practically by a day, the duration of ARVI, including influenza. Terapevticheskii arkhiv • 2022-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 36286922 ↗ |
| Can This Approach Help? Inside the Latest Research on Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, In this study, the side effects occurred at a comparable rate across the four groups, with no unexpected safety findings observed. Signal transduction and targeted therapy • 2023-01-30 • Phase III Randomized Trial | N = 167 | 88/100 | PMID 36717539 ↗ |
| Can This Approach Help? Inside the Latest Research on Hemagglutination Inhibition Antibody Titers as Mediators of Influenza Vaccine HAI titers partially mediate influenza vaccine efficacy against influenza A(H1N1), A(H3N2), and B/Victoria. The Journal of infectious diseases • 2024-07-25 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39052734 ↗ |
H1N1 Flu (Swine Flu) Patient Community & “People Like Me” Threads
Filter H1N1 Flu (Swine Flu) community threads and patient logs by age, biological sex, dosage, and treatment duration.